Connect with us

Golden Knights Injury Update

BREAKING: Robin Lehner To Miss Entire 2022-23 Season

Published

on

Robin Lehner, Vegas Golden Knights

Vegas Golden Knights starting goaltender Robin Lehner will miss the entire 2022-23 season as he will require hip surgery. The announcement was made by the Golden Knights via Twitter on Thursday morning.

A timeline for Lehner’s recovery, as well as a date for his surgery, will be determined at a later date.

Lehner is entering his fourth year with the Golden Knights. He struggled in 2021-22 after taking over the starting role from Marc-Andre Fleury full-time. Last season he posted a .907 save percentage and a 2.83 goals against average in 44 games played.

He has three seasons remaining on his contract with the VGK, which pays him $5 million per season. Lehner will most certainly be placed on LTIR by the VGK. The Golden Knights can use this cap space to re-sign Nicolas Hague and Jake Leschyshyn, who remain unsigned restricted free agents.

All the best to Lehner as he goes through a challenging time in his hockey career.

The Golden Knights have Laurent Brossoit, Logan Thompson, and Michael Hutchinson as other goaltenders on the team.

This story is being updated in real-time. Check back later for more updates.

Welcome to your new home for Vegas Golden Knights breaking news, analysis and opinion. Like us on Facebook, follow us on Twitter and don't forget to subscribe to VHN+ for all of our members-only content the entire Vegas Hockey Now crew plus an ad-free browsing experience.

Owen Krepps covers the Vegas Golden Knights for Vegas Hockey Now. A 2022 Robert Morris University graduate, he has previously written for RMU Sentry Media, Colonial Sports Network, The Titusville Herald, Pittsburgh Sports Now, and Pittsburgh Hockey Now.

Click to comment
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Get VHN in your Inbox

Enter your email address to receive notifications of new posts by email.

VHN on Facebook

Vegas Team & Cap Info

Get VHN in your inbox.

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.